Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Search by expertise, name or affiliation
Malignant peritoneal mesothelioma: A review
Joseph Kim
, Shanel Bhagwandin
,
Daniel M. Labow
Icahn School of Medicine at Mount Sinai
Surgery
Research output
:
Contribution to journal
›
Review article
›
peer-review
132
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Malignant peritoneal mesothelioma: A review'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Malignant Peritoneal Mesothelioma
100%
Malignancy
16%
Treatment Strategy
16%
Systemic Therapy
16%
Disease Burden
16%
Diagnostic Strategy
16%
Starvation
16%
Cytoreductive Surgery
16%
Asbestos
16%
Life Expectancy
16%
Abdominal Cavity
16%
Epidemiology
16%
Disease Spread
16%
Peritoneum
16%
Abdomen
16%
Mesothelioma
16%
Visceral Pleura
16%
Industrial Pollutants
16%
Metastatic Spread
16%
Malignant Pleural Mesothelioma
16%
Non-specific Symptoms
16%
Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
16%
Toxic Exposures
16%
Treatment Advances
16%
Serosal Membranes
16%
Abdominal Complications
16%
Medicine and Dentistry
Peritoneum Mesothelioma
100%
Diseases
33%
Cancer
16%
Disease Burden
16%
Life Expectancy
16%
Serous Membrane
16%
Cohort Effect
16%
Peritoneum
16%
Systemic Therapy
16%
Visceral Pleura
16%
Pleura Mesothelioma
16%
Mesothelioma
16%
Cytoreductive Surgery
16%
Intraperitoneal Chemotherapy
16%
Abdominal Cavity
16%
Pharmacology, Toxicology and Pharmaceutical Science
Peritoneal Mesothelioma
100%
Diseases
50%
Life Expectancy
16%
Pleura Mesothelioma
16%
Mesothelioma
16%
Intraperitoneal Chemotherapy
16%